R. Michael Linden is an associate professor at the Carl C. Icahn Institute for Gene Therapy and Molecular Medicine and the Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029. He is funded by the National Institutes of Health and by PrimeBioTech, Paris, France Michael.Linden@mssm.edu
Gene-deleted adenovirus vectors modified to carry the Sleeping Beauty transposon machinery achieve long-term transgene stabilization and expression.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
